Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: ECT026
MIFTS: 53

Ectopic Pregnancy

Categories: Fetal diseases, Rare diseases, Reproductive diseases
Genes Tissues Related diseases Publications Pathways Symptoms & Phenotypes Drugs
Sources

Aliases & Classifications for Ectopic Pregnancy

About this section

MalaCards integrated aliases for Ectopic Pregnancy:

Name: Ectopic Pregnancy 12 77 54 44 15 74
Pregnancy, Ectopic 45
Pregnancy Ectopic 56
Eccyesis 12

Classifications:

MalaCards categories:
Global: Rare diseases Fetal diseases
Anatomical: Reproductive diseases
See all MalaCards categories (disease lists)
ICD10: 34


External Ids:

Disease Ontology 12 DOID:0060329
ICD9CM 36 633 633.9
MeSH 45 D011271
NCIt 51 C34945
SNOMED-CT 69 34801009
ICD10 34 O00 O00.9 O00.90
UMLS 74 C0032987
Sources

Summaries for Ectopic Pregnancy

About this section
MedlinePlus : 44 The uterus, or womb, is the place where a baby grows when a woman is pregnant. If you have an ectopic pregnancy, the fertilized egg grows in the wrong place, outside the uterus, usually in the fallopian tubes. The result is usually a miscarriage. Ectopic pregnancy can be a medical emergency if it ruptures. Signs of ectopic pregnancy include Abdominal pain Shoulder pain Vaginal bleeding Feeling dizzy or faint Get medical care right away if you have these signs. Doctors use drugs or surgery to remove the ectopic tissue so it doesn't damage your organs. Many women who have had ectopic pregnancies go on to have healthy pregnancies later. Dept. of Health and Human Services Office on Women's Health

MalaCards based summary : Ectopic Pregnancy, also known as pregnancy, ectopic, is related to hydatidiform mole, recurrent, 1 and choriocarcinoma, and has symptoms including pelvic pain and morning sickness. An important gene associated with Ectopic Pregnancy is CGB3 (Chorionic Gonadotropin Subunit Beta 3), and among its related pathways/superpathways are Peptide hormone metabolism and Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors. The drugs leucovorin and Methotrexate have been mentioned in the context of this disorder. Affiliated tissues include uterus, testes and ovary, and related phenotype is homeostasis/metabolism.

Disease Ontology : 12 A female reproductive system disease characterized by the implantation of the embryo outside the uterine cavity.

Wikipedia : 77 Ectopic pregnancy is a complication of pregnancy in which the embryo attaches outside the uterus. Signs... more...

Sources

Related Diseases for Ectopic Pregnancy

About this section

Diseases related to Ectopic Pregnancy via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 146)
# Related Disease Score Top Affiliating Genes
1 hydatidiform mole, recurrent, 1 32.6 CGA CGB3 CGB5
2 choriocarcinoma 30.6 CGA CGB3 CGB5 CGB7
3 ovarian hyperstimulation syndrome 30.3 CGA GNRH1 VEGFA
4 endometriosis 30.2 GNRH1 PAEP VEGFA
5 placental site trophoblastic tumor 30.2 CGB3 CGB5 VEGFA
6 placenta disease 29.1 CGA CGB3 CGB5 CGB7 PAPPA PGF
7 pelvic inflammatory disease 11.6
8 chlamydia 11.5
9 gestational trophoblastic tumor 11.4
10 hydatidiform mole, recurrent, 2 11.1
11 diethylstilbestrol syndrome 11.1
12 mixed germ cell tumor 10.4 CGA CGB3
13 sacrococcygeal teratoma 10.4 CGA CGB7
14 nonseminomatous germ cell tumor 10.4 CGB5 CGB7
15 testicular seminoma 10.4 CGA CGB3
16 anorchia 10.4 CGA CGB5
17 chromosomal triplication 10.3 CGA CGB3
18 infertility 10.3
19 trisomy 22 10.3 CGB7 PAPPA
20 hydrocele 10.3 CGA VEGFA
21 testicular cancer 10.2 CGA CGB3 CGB5
22 neovascular glaucoma 10.2 PGF VEGFA
23 kuhnt-junius degeneration 10.2 PGF VEGFA
24 ulcerative stomatitis 10.2 CGB3 CGB7
25 epithelioid hemangioendothelioma 10.2 PGF VEGFA
26 cancer-associated retinopathy 10.2 PGF VEGFA
27 pseudovaginal perineoscrotal hypospadias 10.2 CGA GNRH1
28 salpingitis 10.2
29 appendicitis 10.2
30 triploidy 10.1 CGA CGB7 PAPPA
31 retinal vascular occlusion 10.1 PGF VEGFA
32 seminoma 10.1 CGA CGB3 CGB5 CGB7
33 gestational trophoblastic neoplasm 10.1
34 orofaciodigital syndrome viii 10.1 ADAM12 CGA PAPPA
35 gestational choriocarcinoma 10.1
36 ovarian cyst 10.1
37 ovarian disease 10.0 CGA CGB5 GNRH1 VEGFA
38 arteriovenous malformation 10.0
39 schistosomiasis 10.0
40 teratoma 10.0
41 choriocarcinoma of ovary 10.0
42 mixed ductal-endocrine carcinoma 10.0 CGB3 CGB7
43 leukemia 10.0
44 cystic teratoma 10.0
45 placental insufficiency 9.9 PGF PROK1 VEGFA
46 dermoid cyst 9.9
47 ovarian cancer 9.9
48 adenomyosis 9.9
49 tuberculous salpingitis 9.9
50 thrombosis 9.9

Graphical network of the top 20 diseases related to Ectopic Pregnancy:



Diseases related to Ectopic Pregnancy
Sources

Symptoms & Phenotypes for Ectopic Pregnancy

About this section

UMLS symptoms related to Ectopic Pregnancy:


pelvic pain, morning sickness

MGI Mouse Phenotypes related to Ectopic Pregnancy:

47
# Description MGI Source Accession Score Top Affiliating Genes
1 homeostasis/metabolism MP:0005376 9.32 CGA GNRH1 LIF MYH11 OLFM1 PAPPA
Sources

Drugs & Therapeutics for Ectopic Pregnancy

About this section

Drugs for Ectopic Pregnancy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 167)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
leucovorin Approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 58-05-9 143 6006
2
Methotrexate Approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 1959-05-2, 59-05-2 126941
3
Mifepristone Approved, Investigational Phase 4,Not Applicable 84371-65-3 55245
4
Misoprostol Approved Phase 4,Not Applicable 59122-46-2 5282381
5
Estradiol Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2 50-28-2 5757
6
Polyestradiol phosphate Approved Phase 4,Phase 3,Phase 2 28014-46-2
7
Progesterone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 57-83-0 5994
8
Buserelin Approved, Investigational Phase 4 57982-77-1
9
Trimethobenzamide Approved, Investigational Phase 4 138-56-7 5577
10
Levonorgestrel Approved, Investigational Phase 4 797-63-7, 17489-40-6 13109
11
Doxycycline Approved, Investigational, Vet_approved Phase 4 564-25-0 54671203
12
Azithromycin Approved Phase 4 83905-01-5 447043 55185
13
Tamoxifen Approved Phase 4 10540-29-1 2733526
14
Norgestrel Approved Phase 4 6533-00-2 13109
15
Ethinyl Estradiol Approved Phase 4 57-63-6 5991
16
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 59-30-3 6037
17 Dermatologic Agents Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
18 Folic Acid Antagonists Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
19 Nucleic Acid Synthesis Inhibitors Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
20 Antirheumatic Agents Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
21 Immunologic Factors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
22 Vitamin B Complex Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
23 Vitamin B9 Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
24 Immunosuppressive Agents Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
25 Folate Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
26 Antimetabolites Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
27 Antimetabolites, Antineoplastic Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
28 Oxytocics Phase 4,Phase 1
29 Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
30 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
31 Luteolytic Agents Phase 4,Phase 3,Phase 2,Not Applicable
32 Contraceptives, Oral Phase 4,Phase 2
33 Anti-Ulcer Agents Phase 4,Phase 3
34 Gastrointestinal Agents Phase 4,Phase 3
35 Contraceptives, Postcoital Phase 4
36 Contraceptive Agents Phase 4,Phase 3,Phase 2,Not Applicable
37 Antacids Phase 4,Phase 3
38 Hormones Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
39 Chorionic Gonadotropin Phase 4,Phase 3,Phase 2,Not Applicable
40 Antineoplastic Agents, Hormonal Phase 4,Phase 3,Phase 2,Not Applicable
41 Triptorelin Pamoate Phase 4,Phase 2,Phase 3,Not Applicable
42 Progestins Phase 4,Phase 3,Phase 2,Not Applicable
43 Estrogen Receptor Antagonists Phase 4,Phase 2,Not Applicable
44 Estradiol 17 beta-cypionate Phase 4,Phase 3,Phase 2
45 Estradiol 3-benzoate Phase 4,Phase 3,Phase 2
46 Estrogens Phase 4,Phase 3,Phase 2,Not Applicable
47 Bone Density Conservation Agents Phase 4
48 Estrogen Antagonists Phase 4,Phase 2,Not Applicable
49 Contraceptives, Oral, Combined Phase 4,Phase 2
50 Follicle Stimulating Hormone Phase 4,Phase 3,Phase 1,Phase 2

Interventional clinical trials:

(show top 50) (show all 171)
# Name Status NCT ID Phase Drugs
1 Laparascopy Versus Laparatomy in the Management of Ruptured Ectopic Pregnancy Unknown status NCT01932957 Phase 4
2 BHCG Level in Day 4,7, in Comparison to Day 10 as an Indicator for Treatment Success Unknown status NCT01860690 Phase 4 Methotrexate
3 Evaluation of Therapeutic Strategies for Treatment of Ectopic Pregnancies (EP) and Evaluation of Subsequent Fertility Unknown status NCT00137982 Phase 4
4 Medical Abortion at Gestational Age of 8 to ≤9 Weeks Versus >9 to ≤12 Weeks Unknown status NCT02745093 Phase 4 Mifepristone;Misoprostol
5 Effectiveness Of Expectant Management In The Tubal Ectopic Pregnancy Completed NCT01876004 Phase 4 Methotrexate;Placebo
6 Comparison of Single and Multiple-dose Methotrexate Therapy for Ectopic Pregnancy Completed NCT01662167 Phase 4 Single;Multipe
7 Efficacy of Corifollitropin Alfa Versus Follitropin Beta in Aged IVF (In-vitro Fertilization) Patients Completed NCT02466204 Phase 4 corifollitropin alfa;Follitropin Beta
8 Half-Dose Depot Triptorelin Versus Reduced-Dose Daily Buserelin Completed NCT00461916 Phase 4 Half-Dose Depot Triptorelin;Reduced-Dose Daily Buserelin
9 Recombinant Follicle Stimulating Hormone (FSH) (Gonal-f®): Use in Ovulation Induction Completed NCT01081626 Phase 4 Recombinant FSH (follitropin alpha)
10 Effectiveness, Safety and Immunogenicity of GSK Biologicals' HPV Vaccine GSK580299 (Cervarix TM) Administered in Healthy Adolescents Completed NCT00534638 Phase 4
11 TICON-Day 3, Time Lapse Versus Conventional Method in Day 3 Embryo Culture and Assessment Recruiting NCT03164551 Phase 4
12 Safety and Protective Effect Study of GSK Biologicals' Human Papillomavirus (Types 16, 18) Vaccine, Adsorbed (GSK580299) in Healthy Female Subjects From the HPV-039 Study Active, not recruiting NCT03629886 Phase 4
13 Azithromycin Compared With Doxycycline for Treating Anorectal Chlamydia Trachomatis Infection Concomitant to a Vaginal Infection Not yet recruiting NCT03532464 Phase 4 azithromycin;doxycycline
14 The Effect of Tamoxifen on Clinical Outcome in Women With Thin Endometrium Undergoing Frozen Thawed Cycle. Not yet recruiting NCT03060304 Phase 4 Tamoxifen;estradiol valerate
15 Natural Versus Artificial Cycle for Frozen-Thawed Embryo Transfer Not yet recruiting NCT03642665 Phase 4 Natural cycle;Estradiol Valerate;Micronized progesterone
16 Pituitary Down-regulation Before IVF for Women With Endometriosis Terminated NCT01757249 Phase 4 Combined Oral Contraceptive Pill (Microgynon 30)
17 Low-dose Gonal-f® in Ovulation Induction Terminated NCT01871532 Phase 4 Gonal-f®
18 Two-Dose Methotrexate for Ectopic Pregnancy Completed NCT00194272 Phase 3 Methotrexate
19 Methotrexate Treatment for Ectopic Pregnancy Completed NCT01855568 Phase 3
20 A Clinical Trial to Evaluate the Efficacy and Safety of DR-2011 for In Vitro Fertilization Completed NCT00615251 Phase 3 DR-2011;Crinone 8%
21 Phase 3 Trial to Evaluate the Efficacy and Safety of COL-1620 Vaginal Progesterone Gel Completed NCT01863680 Phase 3 COL-1620;Gonadotropin-releasing hormone (GnRH) analogue;Follicle-stimulating hormone (FSH);Human Chorionic Gonadotropin (hCG)
22 The Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study Completed NCT01249365 Phase 3
23 Corifollitropin Alfa in Participants Undergoing Repeated Controlled Ovarian Stimulation (COS) Cycles Using a Multiple Dose Gonadatropin Releasing Hormone (GnRH) Antagonist Protocol (Study 38825)(P05714) Completed NCT00696878 Phase 3 Corifollitropin alfa;Progesterone
24 A Study Using Recombinant Human Luteinizing Hormone (r-hLH, Luveris®) in the Treatment of Chinese Women With Hypogonadotropic Hypogonadism Completed NCT01084265 Phase 3 Recombinant human luteinizing hormone (r-hLH);Recombinant human follicle-stimulating hormone (r-hFSH);Human chorionic gonadotropin (hCG)
25 Endometrial Injury and IVF Outcome Parameters in Patients With Failed IVF Cycles Completed NCT01798862 Phase 2, Phase 3
26 Impact of Local Biopsy to the Endometrium Prior to Controlled Ovarian Stimulation on Clinical Pregnancy Completed NCT01064193 Phase 3
27 Efficacy, Immunogenicity and Safety of GSK Biologicals' HPV GSK 580299 Vaccine in Healthy Chinese Female Subjects Completed NCT00779766 Phase 3
28 GNRH Agonist Trigger and Modified Luteal Phase Adding a Bolus of GnRHa at the Time of Implantation: a RCT Completed NCT03039049 Phase 3 Triptorelin 0.1 mg
29 A Study to Assess if Scratching the Lining of the Womb Prior to IVF Treatment Increases the Chances of Pregnancy Completed NCT01882842 Phase 2, Phase 3
30 Evaluation of Immunogenicity and Safety of Two 2-dose Human Papillomavirus (HPV) Vaccine Schedules in 9-14 Year Old Girls Completed NCT01381575 Phase 3
31 Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine (GSK580299) in Healthy Female Subjects 10-25 Years of Age. Completed NCT00481767 Phase 3 Placebo Al(OH)3
32 Human Papilloma Virus (HPV) Vaccine Efficacy Trial Against Cervical Pre-cancer in Young Adults With GlaxoSmithKline (GSK) Biologicals HPV-16/18 Completed NCT00122681 Phase 3
33 Extension Study of the Efficacy of the GSK 580299 Vaccine in Japanese Women Vaccinated in the Primary NCT00316693 Study Completed NCT00929526 Phase 3
34 Analysis of Two Therapeutic With Cetrotide® in Polycystic Ovarian (PCO) Women in Assisted Reproductive Technology (ART) Completed NCT01185704 Phase 3 Cetrorelix acetate;Cetrorelix acetate;Recombinant Human Choriogonadotropin (r-hCG);Recombinant human follicle stimulating hormone (r-hFSH)
35 Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age and Older Completed NCT00294047 Phase 3
36 PERgoveriS In Stratified Treatment for Assisted Reproductive Technique Completed NCT01297465 Phase 3 Gonal-f®;Pergoveris®;Pergoveris®;Recombinant human chorionic gonadotropin (r-hCG)
37 Optimal Treatment for Women With a Persisting Pregnancy of Unknown Location Recruiting NCT02152696 Phase 3 Methotrexate
38 Hydroxychloroquine (HCQ) for Recurrent Pregnancy Loss Recruiting NCT03305263 Phase 3 Hydroxychloroquine;Hydroxychloroquine placebo
39 Recombinant LH Prior to Ovarian Stimulation in Poor Ovarian Responders (PRE-LH) Recruiting NCT03741699 Phase 3 Pre-treatment with rLH (Luveris 75 IU),
40 Recombinant FSH Investigation in the Treatment of Infertility With Assisted Reproductive Technology (ART) (RITA-1) Recruiting NCT03740737 Phase 3 Follitropin delta
41 Recombinant FSH Investigation in the Treatment of Infertility With Assisted Reproductive Technology (ART) (RITA-2) Recruiting NCT03738618 Phase 3 Follitropin delta;Placebo
42 Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Pan-Asian Women Recruiting NCT03296527 Phase 3 Follitropin alfa;Follitropin delta
43 Long Antagonist Protocol for IVF With Single Luteal Dose of Degarelix Recruiting NCT03240159 Phase 3 Degarelix
44 Methotrexate Single-dose Treatment and Methotrexate/Actinomycin-D Single-dose Treatment in Low-Risk Gestational Trophoblastic Neoplasia Active, not recruiting NCT01823315 Phase 3 MTX 1;MTX 2
45 G-CSF Administration in IVF in a Preferable Preceptive Endometrium Score Not yet recruiting NCT03163862 Phase 2, Phase 3 G-CSF administration;Saline Solution
46 Impact of Ultra-long Versus Long Down-regulation Protocol on IVF/ICSI in Adenomyosis Not yet recruiting NCT03940807 Phase 3 11.25mg GnRH agonist;0.1 mg GnRH agonist;25 µg transdermal oestradiol
47 Oestradiol Pre-treatment in an Ultrashort Flare GnRH Agonist/GnRH Antagonist Protocol in Poor Responders Undergoing IVF Terminated NCT01798836 Phase 2, Phase 3
48 Study to Evaluate if the Addition of r-hLH (Luveris®) to FSH From Day 8 of Ovarian Stimulation is Able to Decrease Total FSH Dose and to Improve Cycle Outcome in Infertile Women Undergoing ART, Who Required High FSH Dose in a Previous Cycle Terminated NCT01071200 Phase 3 Recombinant human Follicle Stimulating Hormone (r-hFSH) and Recombinant human Luteinizing Hormone (r-hLH);r-hFSH
49 Endometrial Injury for Assisted Reproduction Terminated NCT01132144 Phase 3
50 Nifedipine Treatment on Uterine Contractility in IVF Unknown status NCT02072291 Phase 2 Nifedipine

Search NIH Clinical Center for Ectopic Pregnancy

Inferred drug relations via UMLS 74 / NDF-RT 52 :


Cochrane evidence based reviews: pregnancy, ectopic

Sources

Genetic Tests for Ectopic Pregnancy

About this section
Sources

Anatomical Context for Ectopic Pregnancy

About this section

MalaCards organs/tissues related to Ectopic Pregnancy:

42
Uterus, Testes, Ovary, Heart, Endothelial, Placenta, Liver
Sources

Publications for Ectopic Pregnancy

About this section

Articles related to Ectopic Pregnancy:

(show top 50) (show all 3045)
# Title Authors Year
1
Relation between Chlamydia trachomatis infection and pelvic inflammatory disease, ectopic pregnancy and tubal factor infertility in a Dutch cohort of women previously tested for chlamydia in a chlamydia screening trial. ( 30606817 )
2019
2
Risk of ectopic pregnancy and tubal infertility following gonorrhoea and chlamydia infections. ( 30778532 )
2019
3
Genetically Related Choriocarcinoma Developing 5 Yr After a Complete Hydatidiform Mole and Simulating a Cornual Ectopic Pregnancy. ( 31033803 )
2019
4
Deregulation of miR-324/KISS1/kisspeptin in early ectopic pregnancy: mechanistic findings with clinical and diagnostic implications. ( 30707968 )
2019
5
Persistent omental trophoblastic implantation following salpingostomy, salpingectomy and methotrexate for ectopic pregnancy: A case report. ( 30723694 )
2019
6
Can early βhCG change and baseline progesterone level predict treatment outcome in patients receiving single dose Methotrexate protocol for tubal ectopic pregnancy? ( 30737586 )
2019
7
Levonorgestrel intrauterine contraceptive systems (13.5 mg and 52 mg) and risk of ectopic pregnancy. ( 30737766 )
2019
8
Rupture of an unsuspected ectopic pregnancy following a hysterosalpingography-A case report. ( 30743220 )
2019
9
3-D Ultrasound for Ectopic Pregnancy Diagnosis: Looking Beyond the Grey-Scale. ( 30772314 )
2019
10
Ruptured Ectopic Pregnancy in the Presence of an Intrauterine Device. ( 30775665 )
2019
11
Ruptured Tubal Ectopic Pregnancy at Fifteen Weeks Gestational Age. ( 30775668 )
2019
12
Hysteroscopic management of an interstitial ectopic pregnancy. ( 30776496 )
2019
13
Temporal trends in severe morbidity and mortality associated with ectopic pregnancy requiring hospitalisation in Washington State, USA: a population-based study. ( 30782901 )
2019
14
Successful laparoscopic treatment of an abdominal pregnancy implanted in the utero-ovarian ligament: a case report of a rare form of ectopic pregnancy. ( 30795700 )
2019
15
Correlation between Ovarian Reserve and Incidence of Ectopic Pregnancy after In Vitro Fertilization and Embryo Transfer. ( 30799591 )
2019
16
Emphasis In The Off Label Methotrexate Use In The Ectopic Pregnancy. ( 30807765 )
2019
17
Evaluation of a follow-up customized strategy for women treated with methotrexate for an ectopic pregnancy: An observational study. ( 30877908 )
2019
18
Letter to the Editors - Correspondence: Management of a cornual ectopic pregnancy. ( 30878555 )
2019
19
Bleeding nodule on the ligamentum hepatogastricum - an unexpected ectopic pregnancy. ( 30878644 )
2019
20
Various BhCG monitoring protocols for predicting the success of single-dose methotrexate in the treatment of ectopic pregnancy. ( 30892124 )
2019
21
Severe morbidity with ectopic pregnancy is associated with late presentation. ( 30915881 )
2019
22
Direct Methotrexate Injection into the Gestational Sac for Nontubal Ectopic Pregnancy: A Review of Efficacy and Outcomes from a Single Institution. ( 30930212 )
2019
23
Cervical Ectopic Pregnancy: A Rare Site of Implantation. ( 31003816 )
2019
24
Cesarean scar ectopic pregnancy: Case report☆. ( 31007806 )
2019
25
ACOG Practice Bulletin No. 193: Tubal Ectopic Pregnancy: Correction. ( 31022116 )
2019
26
Ectopic pregnancy and outcomes of future intrauterine pregnancy. ( 31056305 )
2019
27
Reply. ( 31062636 )
2019
28
Cesarean section scar ectopic pregnancy - a management conundrum: a case report. ( 31072411 )
2019
29
Impact of salpingectomy for ectopic pregnancy on the ovarian response during IVF Stimulation. ( 31108239 )
2019
30
Ectopic pregnancy outcomes in patients discharged from the emergency department. ( 29501067 )
2019
31
Coexistence of a Tubal Ectopic Pregnancy and Tubal Leiomyoma. ( 29704678 )
2019
32
A Rare Case of Ectopic Pregnancy at a Previous Laparoscopic Adenomyomectomy Scar. ( 29807141 )
2019
33
Laparoscopic Resection of Cesarean Scar Ectopic Pregnancy after Unsuccessful Systemic Methotrexate Treatment. ( 29890356 )
2019
34
Laparoscopic Management of Retroperitoneal Ectopic Pregnancy. ( 30031205 )
2019
35
Frozen blastocyst transfer reduces incidence of ectopic pregnancy compared with fresh blastocyst transfer: a meta-analysis. ( 30129787 )
2019
36
Peritoneal reimplantation of trophoblastic tissue following laparoscopic treatment of ectopic pregnancy: A case report and review of literature. ( 30189254 )
2019
37
Primary omental ectopic pregnancy: a case report. ( 30207509 )
2019
38
Laparoscopic Management of Cervical Ectopic Pregnancy with Devascularization. ( 30243686 )
2019
39
Methotrexate Administration to Patients With Presumed Ectopic Pregnancy Leads to Methotrexate Exposure of Intrauterine Pregnancies. ( 30244479 )
2019
40
Ectopic pregnancy following oral levonorgestrel emergency contraception use. ( 30246476 )
2019
41
Partial tubal devascularisation: a novel procedure for tubal conservation in ectopic pregnancy. ( 30286665 )
2019
42
An Atypical Presentation of Ectopic Pregnancy With Unicornuate Uterus and Undescended Fallopian Tube. ( 30385208 )
2019
43
Ectopic pregnancy rate in Iranian midwifery clients and infertile patients treated by assisted reproductive technologies. ( 30426707 )
2019
44
Chronic tubal ectopic pregnancy following clinically successful methotrexate treatment for an acute ectopic: a review of the literature. ( 30428745 )
2019
45
Fatal ruptured ectopic pregnancy - a case report. ( 30489187 )
2019
46
Therapeutic abortion and ectopic pregnancy: alternative sources for fetal stem cell research and therapy in Iran as an Islamic country. ( 30535614 )
2019
47
Regarding "Technique for the Laparoscopic Management of a Cornual Ectopic Pregnancy". ( 30590130 )
2019
48
Diagnosis and laparoscopic management of a 5-week ectopic pregnancy in a rudimentary uterine horn: A case report. ( 30591910 )
2019
49
Previously asymptomatic ruptured tubal ectopic pregnancy at over 10 weeks' gestation: Two case reports. ( 30591911 )
2019
50
Conservative Management of Retroperitoneal Ectopic Pregnancy by Computed Tomography-Guided Methotrexate Injection in the Gestational Sac: Two Case Reports and Literature Review. ( 30611975 )
2019
Sources

Variations for Ectopic Pregnancy

About this section
Sources

Expression for Ectopic Pregnancy

About this section
Search GEO for disease gene expression data for Ectopic Pregnancy.
Sources

GO Terms for Ectopic Pregnancy

About this section

Cellular components related to Ectopic Pregnancy according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.65 CGA CGB3 CGB5 CGB7 GNRH1 LIF
2 extracellular region GO:0005576 9.44 ADAM12 CGA CGB3 CGB5 CGB7 GNRH1

Biological processes related to Ectopic Pregnancy according to GeneCards Suite gene sharing:

(show all 15)
# Name GO ID Score Top Affiliating Genes
1 multicellular organism development GO:0007275 9.97 GNRH1 LIF OLFM1 PAEP PGF VEGFA
2 positive regulation of cell proliferation GO:0008284 9.83 CGA LIF PGF PROK1 VEGFA
3 positive regulation of angiogenesis GO:0045766 9.71 ADAM12 PGF VEGFA
4 female pregnancy GO:0007565 9.63 GNRH1 PAPPA PGF
5 sprouting angiogenesis GO:0002040 9.55 PGF VEGFA
6 cell-cell signaling GO:0007267 9.55 CGB3 CGB5 CGB7 GNRH1 PGF
7 hormone-mediated signaling pathway GO:0009755 9.54 CGB3 CGB5 CGB7
8 cardiac muscle fiber development GO:0048739 9.52 MYH11 VEGFA
9 vascular endothelial growth factor signaling pathway GO:0038084 9.51 PGF VEGFA
10 positive regulation of cell division GO:0051781 9.5 PGF PROK1 VEGFA
11 induction of positive chemotaxis GO:0050930 9.48 PGF VEGFA
12 peptide hormone processing GO:0016486 9.43 CGA CGB3 CGB5
13 positive regulation of mast cell chemotaxis GO:0060754 9.4 PGF VEGFA
14 regulation of signaling receptor activity GO:0010469 9.28 CGA CGB3 CGB5 CGB7 GNRH1 LIF
15 female gamete generation GO:0007292 9.13 CGB3 CGB5 CGB7

Molecular functions related to Ectopic Pregnancy according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 growth factor activity GO:0008083 9.26 LIF PGF PROK1 VEGFA
2 hormone activity GO:0005179 8.92 CGA CGB3 CGB7 GNRH1
Sources

Sources for Ectopic Pregnancy

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....